Elevated ankle blood pressure (ABP) may be one of the earliest signs of subclinical atherosclerosis. However, its behavior in different degrees of atherosclerotic vascular damage has not been well characterized. We examined the association of ABP and brachial exercise blood pressure with the incidence of future coronary events. A cohort of 3808 consecutive ambulatory persons (mean age 50 years, 34% women), referred to a symptom-limited exercise test and free of cardiovascular events at baseline, was prospectively followed up for 15 years. Altogether, 383 (80 fatal and 303 non-fatal) incident coronary events occurred. Cox proportional hazards models, adjusting for several conventional risk factors, were used to analyse the independent association of ABP with the risk of an incident coronary heart disease (CHD) event. Persons with normal ankle, brachial resting and brachial exercise blood pressures were taken as the reference group. Other groups were formed on the basis of ankle and exercise blood pressures and compared with the reference group. Even in persons among whom the elevated ABP was the only abnormal finding, the multivariate adjusted hazard ratio (HR) of a future CHD event was significantly elevated (HR ¼ 1.60, 95% confidence interval 1.20-2.14, Po0.0001). In general, the HRs were higher for fatal events than for non-fatal events. The measurement of ABP could be an inexpensive and non-invasive tool to detect elevated risk of a CHD event.
Introduction
The ankle blood pressure (ABP) has usually been indexed to brachial blood pressure to form the ankle-brachial blood pressure index (ABI). Low values of ABI (o0.95) signal advanced peripheral artery disease and significantly elevated risk of a major cardiovascular disease (CVD) event. [1] [2] [3] [4] [5] [6] [7] Stenotic changes leading to abnormally low ABI are, however, relatively rare in middle-aged persons. 4, 5 Furthermore, also elevated ABI (41.40) or high ABP may be associated with increased risk, although the literature is somewhat conflicting. [7] [8] [9] [10] [11] The behavior of the ABP in different degrees of atherosclerotic vascular damage has not been well characterized and very few studies have attempted to use the ABP as a risk marker without indexing it to the brachial blood pressure.
In the beginning of the atherosclerotic process and arterial stiffening the ABP is determined by local factors only, that is, blood pressure and the elastic properties of arteries, and the elevated ABP may be one of the earliest signs of subclinical vascular damage. 12 More advanced atherosclerosis is propagated from the arterial wall to the arterial lumen and stenotic changes along the conduit vessels decrease the ABP. This step is reached when physical exercise causes an exaggerated blood pressure reaction while the ABP is normal. Accordingly, we hypothesized that categorizing the persons in a logical manner on the basis of the ABP and exercise brachial blood pressure could provide an even more sensitive tool than ABI for detecting early arterial changes.
We have followed up for an average of 15 years a cohort of 3808 middle-aged persons (mean age 50 years, range 15-84 years, 34% women) whose ABP and exercise brachial blood pressure, as well as physical working capacity, were measured at baseline. The aim of this study was to assess the association of ABP, together with the resting and exercise brachial blood pressures, with coronary morbidity and mortality during the follow-up.
Methods

Study population
Subjects for this investigation were derived from a group of 4038 consecutive ambulatory persons, who underwent symptom-limited bicycle exercise testing at the Deaconess Institute in Helsinki between August 1989 and December 1995. The persons were referred by occupational health physicians to a symptom-limited exercise testing to rule out coronary heart disease (CHD) and evaluate physical fitness. Persons with a documented history of myocardial infarction (MI), percutaneous coronary angioplasty, coronary artery bypass grafting or stroke were excluded from the analysis. The patients with a positive ischaemic finding in the exercise test but no history of a hard cardiovascular event were included in the follow-up and analyses. The final study group consisted of 3808 persons. Of them, 759 persons were under medication and the antihypertension medication was the most important drug therapy (412 used b-blockers, 48 diuretics and 185 used angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers). In all, 52 persons had medication for diabetes.
The study was approved by the Ethical Committee of the National Public Health Institute.
Baseline vascular examination
Brachial blood pressure was measured by trained technicians using the auscultatory method with a standard mercury sphygmomanometer from the left arm of the subject in a supine position after a 5 min rest. The ABP was simultaneously measured from the right leg using a Doppler probe with a mercury sphygmomanometer. The posterior tibial artery was used, and if absent, the ABP measurements were taken from the dorsalis pedis artery.
Exercise testing was conducted on an electrically braked bicycle. The starting load was 50 W for men and 40 W for women, and the load was increased every 3 min by 50 W for men and 40 W for women. Blood pressure was measured with a sphygmomanometer at 2 min at all loads and immediately before test termination. Readings were recorded to the nearest 5 mm Hg. The test was continued until the subject refused to continue, or until the attending physician felt it unsafe to continue. The criteria for myocardial ischaemia during the exercise test were ischaemic changes in electrocardiogram defined as ST depression 41.0 mm at 60 ms after the J-point with typical ischaemic complaints (chest paint or shortness of breath).
Other baseline characteristics
Other risk factors assessed at baseline were age, gender, body mass index (BMI), smoking status, medical history, family history of early cardiovascular disease (under 60 years), physical working capacity, self-reported history of cardiovascular diseases, total cholesterol and glucose. This information was collected by the attending physician (HH) by interviewing the patient before the exercise test. Height and weight were asked by nurses and BMI was calculated.
Blood pressure groups Subjects were divided into five groups based on the ABP at rest and exercise brachial blood pressures at moderate exercise level (men 150 W, women 80 W): (1) normal (reference) group, in which both ankle and exercise brachial blood pressures were within normal limits; (2) persons with elevated ABP (X175 mm Hg) but normal exercise brachial blood pressure (p215 mm Hg); (3) persons with elevated ankle (X175 mm Hg) and exaggerated exercise brachial blood pressure (4215 mm Hg); (4) exaggerated exercise brachial blood pressure (4215 mm Hg), but normal ABP (o175 mm Hg); and (5) persons who could not be classified. Groups were constructed because they made sense pathophysiologically and because the ABP has a U-shaped association with the risk of a coronary event and cannot therefore be analysed as a continuous variable. As there are no established reference values for the ABP or the brachial exercise blood pressure, we chose our cut-points (175 and 215 mm Hg) arbitrarily to create groups of reasonable size. Group 4 consisted of persons with a discrepancy between the ankle and exercise brachial blood pressures, which suggested haemodynamically significant stenotic changes along the conduit vessels. The group 5 could not tolerate the moderate exercise level (men 150 W and women 80 W) because of specified reason (for example, ischaemic heart disease) or unspecific reason (for example, poor physical fitness). This group 5 was included in the analyses for completeness and secondly to examine the risk associated with poor physical fitness.
Follow-up and definition of outcomes
The end point of the study was a major coronary event, that is, coronary death or first non-fatal coronary event, including MI, percutaneous coronary angioplasty or coronary artery bypass graft surgery. The mortality and morbidity follow-up data were available up to 15 years (range 12-15 years) after the exercise test, until 31 December 2006. Every resident of Finland has a unique personal identification code that was used for record linkage of the study data with nation-wide, computerized healthcare registers. Deaths were ascertained form the national Causes-of-Death Register. Non-fatal MIs and revascularizations were identified from the national Hospital Discharge Register. These registers cover all deaths and hospitalizations in Finland. Thus, the coverage of follow-up was 100% for events that occurred in Finland.
The 9th version of the International Classification of Diseases (ICD-9) was used in Finland for coding of causes of death and hospitalizations until 31 December 1995, and the 10th version (ICD-10) after that. Revascularizations were coded according to the Nordic Medico-Statistical Committee (NOMESCO) Classification. 13 From the Causes of Death Register, we took coronary deaths events with the ICD-9 codes 410-414 or 798 or the ICD-10 codes I20-I25, I46, R96 or R 98 as the underlying cause of death. From the Hospital Discharge Register, we took non-fatal MI events hospitalizations with the ICD-9 codes 410 or 4110, or the ICD-10 codes I21-I22 and I20.0.
Altogether, 383 coronary events were observed during the follow-up. Of them, 80 were fatal and 303 non-fatal. As a whole, the study consisted of 52 985 person-years of follow-up.
Statistical methods
Data are expressed as mean±s.d. for continuous variables, or counts and proportions for categorical variables. The following cardiovascular risk factors were dichotomized: early parental cardiovascular death (yes or no), self-reported elevated cholesterol (46 mmol l -1 , yes or no), self-reported elevated blood glucose (46 mmol l -1 , yes or no) and current smoking (yes or no). Age, BMI, smoking (years, packet day -1 ) and blood pressure (mm Hg) were handled as continuous variables. Student's t-tests or Mann-Whitney U-tests were used for comparisons of normally distributed and skewed continuous variables, between persons with and without a coronary event during the follow-up. Categorical variables were compared using w 2 -tests. Associations between the blood pressure groups and coronary mortality and morbidity (first events) were analysed using Kaplan-Meier curves and logrank tests. Cox proportional hazard models were used for estimating the multivariate-adjusted independent associations of the blood pressure groups with the risk of a coronary event. Results were expressed as hazard ratios (HR) and 95% confidence intervals (CI) compared with the 'normal' group. The basic models were adjusted for age and sex. The larger models were further adjusted for BMI, physical working capacity (METs), self-reported blood glucose and cholesterol, current smoking and early parental history of cardiovascular disease. The proportional hazards assumption was examined graphically and was found to be valid. A gender-specific analysis was also performed to evaluate gender differences.
The statistical analyses were carried out with R (Version 2.6.2).
Results
Baseline characteristics and follow-up events Differences in baseline characteristics between persons with and without a CHD event during the follow-up are presented in Table 1 . Persons with a CHD event were older, especially women (62 years). In persons without a CHD event, almost all risk factors were more favourable compared with the CHD event group. A total of 383 coronary events occurred during the follow-up of 16 years. There were 80 deaths due to CHD, 124 non-fatal MIs, 57 percutaneous coronary angioplasties and 122 persons with coronary artery bypass grafting. Table 2 compares cardiovascular risk factors in different blood pressure groups. The reference group was younger and all risk factors were more favourable compared with the other groups. In the reference group, 4% of individuals had positive exercise test without a CHD event in the follow-up. Figures 1 and 2 show the Kaplan-Meier curves of the five blood pressure groups for all CHD events and fatal CHD events. The curves clearly show the best prognosis of the group with normal ankle and exercise brachial blood pressures and the worst prognosis of the group with poor physical performance (group 5). The curves of the other groups (groups 2-4) are very close to each other between the two extremes.
Multivariate models
The most significant predictors of CHD event were gender (HR, women compared with men, 0.27, 95% CI 0.21-0.36, Po0.0001), age (HR 1.05, 95% CI 1.04-1.07, Po0.0001), systolic blood pressure (HR 1.01, 95% CI 1.01-1.02, Po0.0001), physical performance (METs, HR 0.78, 95% CI 0.73-0.83, Po0.0001), selfreported elevated cholesterol (HR 1.30, 95% CI 1.06-1.59, P ¼ 0.01) and pack-years of smoking (HR 1.02, 95% CI 1.01-1.02, Po0.0001), when positive family history and self-reported elevated blood glucose were adjusted for.
The age-and sex-adjusted and the multivariate adjusted HRs of a CHD event in the different blood pressure groups are shown in Table 3 . Compared with the reference group, the most elevated risk was seen in group with poor physical performance (group 5). The persons with elevated ABP without exaggerated exercise brachial blood pressure and normal or slightly elevated resting brachial blood pressure (144 ± 16/90 ± 10 mm Hg) had 2.03-fold risk of a CHD event compared with the reference group. Further adjustment for traditional risk factors, such as smoking, BMI, parental history of early CVD, selfreported elevated cholesterol and blood glucose attenuated the HR slightly, but it nevertheless remained clearly significant (1.60-fold). The persons with elevated ABP and exaggerated brachial exercise blood pressure at a moderate exercise level had a 1.89-fold risk in the basic model and 1.60-fold risk in the larger model compared with the reference group. In this group, the resting brachial BP was also elevated (153±17/94±10 mm Hg). In persons with a discrepancy between the ankle and exercise brachial blood pressures, that is, normal ABP and elevated exercise brachial blood pressure (group 4), the risk of a future coronary event was even higher (2.34-fold in the age and sex adjusted model and 1.97-fold in the multivariate adjusted model). The resting brachial blood pressure was normal or slightly elevated (135±15/86±9 mm Hg).
In general, the HRs were higher for fatal than for non-fatal CHD events. The persons with poor physical performance (group 5) had the highest risk for fatal outcome (18.0-fold in the basic model and 5.1-fold in the larger model). In groups 2-4, the risk of CHD death was about 3.8-to 4.6-fold in the basic model and about 3.1-to 3.6-fold in the larger model. In addition, the risk of a non-fatal CHD event was significant for all groups in both models.
For comparison, we also calculated the HRs for the usual brachial systolic blood pressure, for exercise brachial blood pressure and for ABP Abbreviation: CHD, coronary heart disease. Model 1: adjusted for age and sex. Model 2: adjusted for age, sex, body mass index, smoking, early parental cardiovascular disease and physical working capacity (METs), selfreported elevated cholesterol and abnormal blood glucose. Please see the Methods section for explanation for the blood pressure groups.
Ankle blood pressure and CHD H Hietanen et al for age and sex only, the HR for a CHD event was 1.23 (0.98-1.55, P ¼ 0.07). In the larger model, the HR was 1.27 (1.00-1.60, P ¼ 0.05). The same comparison was repeated using the fatal CHD event as the outcome. In the basic model, the HR was 1.16 (0.70-1.93, P ¼ 0.6) and in the larger model the HR was 1.20 (0.71-2.04, P ¼ 0.50). In persons with elevated exercise blood pressure (4215 mm Hg) at the moderate exercise level, the HRs for fatal or nonfatal CHD event were also elevated, but not significant in either model. When analysing the ABP alone, we considered four mutually exclusive categories: (1) ABP o175 mm Hg was taken as the 'normal' or reference category; (2) ABP between 175-215 mm Hg was taken as the 'moderately elevated ABP' category; (3) ABP 4215 mm Hg was taken as the 'high ABP' category; and (4) person with abnormal ABI (o0.97) were considered as their own category. In persons with moderately elevated ABP, the HRs for fatal and non-fatal CHD event did not reach statistical significance in any of the models (data not shown). In persons with high ABP, the HR for a fatal and non-fatal CHD event was significantly elevated in the basic model only, 2.11 (1.05-4.27, P ¼ 0.04) and 1.49 (1.12-1.98, P ¼ 0.006). Also, in persons with abnormal ABI, the HR for a fatal and non-fatal CHD event was significant in the basic model only, 3.34 (1.34-8.31, P ¼ 0.01) and 1.91(1.24-2.96, P ¼ 0.004).
Discussion
The main finding of this study was that the elevated ABP, when considered together with exercise blood pressure, was a significant independent predictor of incident CHD event even in persons with normal resting blood pressure. On the other hand, persons with normal ankle and exercise brachial blood pressure had clearly the best prognosis and only 5% of them had a CHD event during the 15-year long follow-up. In groups 2-4, 12-14% of persons had a CHD event during the follow-up. In our earlier study, we have shown that the same categories of ankle and exercise brachial blood pressure predicted total and cardiovascular mortality. 12 The novel features of this study were the specific focus on CHD, including both morbidity and mortality, and the addition of two more years of follow-up time. This study extended the earlier observations by showing that the differences in mortality between the blood pressure groups were largely due to CHD. The HRs for non-fatal CHD events were consistent with those of the fatal events, although somewhat weaker. For comparison, we also provided a separate analysis on the ABP alone as a predictor for CHD.
At least three separate lower-extremity largevessel characteristics determine the ABP: local blood pressure, elastic properties of arteries and pulse wave pressure. Elevated ABP is measured when the arterial stiffness and medial calcification have an influence on the compressibility of the arteries. The interpretation of the ABP measurement is, however, complicated by stenotic changes along the conduit vessels. Although stenotic changes with abnormal ABI are fairly seldom seen in middle-aged persons, 4,5 the influence becomes substantial in elderly persons. We postulate that the discrepancy between the ankle and exercise blood pressures, that is, high exercise brachial blood pressure and normal or low ABP, disclose the persons with haemodynamically significant stenotic changes along the conduit vessels.
The categorization of our study cohort into five subgroups enabled a logical understanding of the chronological sequence of adverse changes in the ABP. In persons with normal ankle, resting brachial and exercise brachial blood pressures the CHD events were rare, even among persons with a positive exercise test. The elevated ABP either with or without elevated exercise brachial blood pressure was significantly associated with the risk of any CHD event and especially with CHD mortality. The elevated ABP might be one of the earliest signs of subclinical vessel damage, because even those persons among whom the elevated ABP was the only abnormal finding, had 1.6-fold higher multivariate-adjusted risk of a CHD event than persons with normal resting brachial, ankle and exercise brachial blood pressure. Persons with exaggerated exercise blood pressure but normal ABP are a more discrete group. With our cut-points (ABP o175 mm Hg and exercise blood pressure at moderate exercise level 4215 mm Hg) they formed a group, in which the risk of a CHD event was 2.0-to 2.3-fold compared with the reference group. Discrepancy between the ankle and exercise blood pressures is a logical step in the progression of atherosclerosis and peripheral artery disease.
Low cardiovascular fitness is associated with premature mortality. The literature is filled with long-term follow-up studies, conducted in relatively healthy populations, or focused on clinical patient populations, which indicate that exercise capacity is a more powerful predictor of mortality than the other established risk factors. [14] [15] [16] [17] Our results are in agreement with this literature, as 44% of our unclassifiable group had a CHD event during the follow-up.
The representativeness of our study cohort is somewhat limited. The persons were referred to the exercise test by occupational health physicians and thus the persons do not represent a random sample of the general population. The study participants were better educated and had higher than average socioeconomic positions. Other limitations of the study are related to the collection of clinical data. The ABP was measured from one leg only. The blood glucose and total cholesterol were self-reported and only half of the persons knew their glucose value. The information on cholesterol and glucose levels was obtained by an interview of a doctor, which gives them some reliability. These values were taken in multivariate analyses, because they were significant predictors of CHD risk as expected. Persons with a CHD event during the follow-up had a more favourable risk factor profile than those without. These differences were controlled for in multivariate models, but some residual confounding cannot be totally excluded. Moreover, a gender-specific analysis was not possible among women because of the small numbers of events but nothing in the results suggested that the effects of the blood pressure groups would differ by gender. These limitations of the study should not affect the validity of the findings on the prognostic value of elevated ABP. Furthermore, most persons with a diagnosed MI during the follow-up had received pharmacological therapy or undergone invasive therapeutic procedures and their lifestyle had changed. Such a bias has probably led to an underestimation, rather than an overestimation, of the prognostic significance of elevated ABP.
In this paper, we showed that the elevated ABPwithout indexing to resting brachial blood pressure-has an independent value as a marker of CHD risk probably because it indicates subclinical vascular damage, that is, arterial stiffness or early atherosclerosis, in asymptomatic middle-aged persons. It identifies high-risk individuals and may provide the necessary motivation to promote lifestyle changes. On the other hand, exaggerated exercise blood pressure reaction with normal ABP reveals those persons with stenotic changes along the conduit vessels. They are likely to need more detailed investigations and intensive therapy. Thus, measurement of the ABP could be an inexpensive and non-invasive tool, which helps to assess the CHD risk and to guide the intensity of other examinations and therapies.
